DADUN
Modulating T Cell Responses by Targeting CD3
Aptamer-iRNAs as therapeutics for cancer treatment
Decoy-based, targeted inhibition of STAT3: A new step forward for B cell lymphoma immunotherapy
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
Therapeutic strategies to enhance tumor antigenicity: making the tumor detectable by the immune system
Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model
ICOS costimulation at the tumor site in combination with CTLA-4 blockade therapy elicits strong tumor immunity
Splicing factor SLU7 prevents oxidative stress-mediated hepatocyte nuclear factor 4α degradation, preserving hepatic differentiation and protecting from liver damage
Multi-omic approaches to breast cancer metabolic phenotyping: applications in diagnosis, prognosis, and the development of novel treatments
Polycythemia vera and essential thrombocythemia patients exhibit unique serum metabolic profiles compared to healthy individuals and secondary thrombocytosis patients
